Aberin, Divina J.
HRN: 24-83-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2025
CEFUROXIME 750MG (VIAL)
01/27/2025
02/03/2025
IV
750 Mg
Q8
S/p Total Thyroidectomy
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes